CORC

在结果中检索

CORC

浏览/检索结果: 共100条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：112/0  |  提交时间：2019/12/05
Development and Validation of a Novel Signature to Predict Overall Survival in "Driver Genenegative" Lung Adenocarcinoma (LUAD): Results of a Multicenter Study 期刊论文
CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 期号: 5
作者:  Cui, Yongmei;  Fang, Wenfeng;  Li, Chaofeng;  Tang, Kejing;  Zhang, Jian
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：43/0  |  提交时间：2020/01/03
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 期刊论文
LABORATORY INVESTIGATION, 2018, 卷号: 98
作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/04
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/04
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:  Xiong, Jianping;  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Qin, Yejun;  Liu, Jianping;  Li, Daiqiang;  Wang, Guoping;  Nie, Xiu
收藏  |  浏览/下载：38/0  |  提交时间：2019/12/05
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文
作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng
收藏  |  浏览/下载：70/0  |  提交时间：2019/11/19

©版权所有 ©2017 CSpace - Powered by CSpace